Table 2.
Correlation between poNLR and clinicopathological variables of patients with PDAC.
| Variables | poNLR≤ 14.1 (n=51) | poNLR> 14.1 (n=46) | P-value |
|---|---|---|---|
| Gender, male/female | 30/21 | 22/24 | 0.278 |
| Age, < 60/ ≥ 60 | 16/35 | 14/32 | 0.921 |
| Differentiation, well and moderate/poor | 13/38 | 16/30 | 0.318 |
| Tumor size, ≤ 4/ > 4 cm | 21/30 | 21/25 | 0.657 |
| TNM stage, I+IIA/IIB+III | 28/23 | 27/19 | 0.707 |
| preCA19-9, < 37/ ≥ 37 U/L | 14/37 | 9/37 | 0.362 |
| preCEA, < 5/ ≥ 5 ng/mL | 37/14 | 39/7 | 0.144 |
| poNeutrophil, ≤ 11.65/ >11.65 *109/L | 23/28 | 5/41 | <0.001 |
| poLymphocyte, < 1.1/ ≥ 1.1 *109/L | 12/39 | 39/7 | <0.001 |
| poALB, <35/ ≥ 35 g/L | 25/26 | 20/26 | 0.585 |
| poALT, ≤ 50/ > 50 U/L | 47/4 | 40/6 | 0.612 |
| poGGT, ≤ 60/ > 60 U/L | 46/5 | 41/5 | 1 |
| poLDH, ≤245/ >245 U/L | 29/22 | 21/25 | 0.270 |
| preLMR, ≤ 5.8/ >5.8 | 29/22 | 36/10 | 0.025 |
| preAGR, ≤ 1.66/ >1.66 | 22/29 | 19/27 | 0.855 |
| preALR, ≤ 0.227/ >0.227 | 18/33 | 21/25 | 0.299 |
| poAGR, ≤0.92/ > 0.92 | 12/39 | 10/36 | 0.833 |
| poALR, ≤ 0.151/ >0.151 | 26/25 | 28/18 | 0.328 |
| △NLR, ≤ 12.1/ >12.1 | 50/1 | 3/43 | <0.001 |
NLR, neutrophil-to-lymphocyte ratio; preCA19-9, preoperative cancer antigen CA19-9; preCEA, preoperative carcino embryonie antigen; poNeutrophil, postoperative neutrophil; poLymphocyte, postoperative lymphocyte; poALB, postoperative albumin; poALT, postoperative alanine aminotransferase; poGGT, postoperative gamma-glutamyltransferase; poLDH, postoperative lactate dehydrogenase; LMR, lymphocyte-to-monocyte ratio; AGR, albumin to gamma-glutamyltransferase ratio; ALR, albumin to lactate dehydrogenase ratio. P values <0.05 are highlighted in bold font.